Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vericiguat in HFrEF with CardioMEMS
NCT06671990Phase 4Not yet recruiting
- Start
- Dec 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of vericiguat in heart failure with reduced ejection fraction (HFrEF). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
vericiguat
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT06671990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06671990.